Stelios Papadopoulos - BG Medicine Insider

BG Medicine Inc -- USA Stock  

USD 0.065  0.025  27.78%

Independent Director

Dr. Stelios B. Papadopoulos, Ph.D., is an Independent Director of BG Medicine, Inc. He has served as Chairman of Fondation Sant, a private charitable foundation whose mission is to provide support for research and education in the life sciences. Dr. Papadopoulos served as Vice Chairman of Cowen and Company, LLC from 2003 until 2006 and as Managing Director from 2000 until 2003. While at Cowen and Company, LLC, he worked as an investment banker focused on the biotech and pharmaceutical sectors. Prior to joining Cowen and Company, LLC, he worked as an investment banker at PaineWebber, Incorporated, from 1987 to 2000, where he was Chairman of PaineWebber Development Corporationration, a PaineWebber subsidiary focusing on biotechnology from 1996 to 2000. Dr. Papadopoulos is a cofounder and Chairman of the Board of Exelixis, Inc. Dr. Papadopoulos currently serves as chairman of the board of Regulus Therapeutics, Inc. and Biogen Inc. and he is a member of the board of directors of Joule Unlimited, Inc. During the past five years, he also served on the board of directors of Anadys Pharmaceuticals, Inc., and Cellzome, Inc. . He is also a member of the board of visitors of Duke University School of Medicine and the board of Global Advisors of the Duke Institute of Health Innovation
Age: 67  Director Since 2012  MBA    
781 890-1199
Papadopoulos holds a Ph.D. in biophysics and an M.B.A. in finance, both from New York University.

Stelios Papadopoulos Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (75.95) % which means that it has lost $75.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (902.64) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives


Frederick DriscollNantKwest Inc
Philip SerlinVascular Biogenics Ltd
Jide ZeitlinVascular Biogenics Ltd
Adam LogalVBI Vaccines Inc
Dan GelvanVascular Biogenics Ltd
Robert RosenNantKwest Inc
John PottsNantKwest Inc
Dmitry GenkinVBI Vaccines Inc
Michael SteinmetzVBI Vaccines Inc
Jecheskiel GonczarowskiVascular Biogenics Ltd
John ThomasNantKwest Inc
Scott RequadtVBI Vaccines Inc
Alan ColowickDimension Therapeutics Inc
Trent DavisVBI Vaccines Inc
Georges GemayelDimension Therapeutics Inc
Richard KusserowNantKwest Inc
David RectorVBI Vaccines Inc
John HohnekerDimension Therapeutics Inc
Sam ChawlaVBI Vaccines Inc
Ron CohenVascular Biogenics Ltd
Michael DybbsDimension Therapeutics Inc

Entity Summary

BG Medicine, Inc. engages in development and commercialization of diagnostic solutions used to guide the patients suffering from heart failure and related disorders in the United States. BG Medicine Inc (BGMD) is traded on OTC Market in USA. It is located in MASSACHUSETTS, U.S.A and employs 5 people. BG Medicine is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Watchlist Optimization Now

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Hide  View All  NextLaunch Watchlist Optimization
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add BG Medicine Inc to your portfolio

Top Management

BG Medicine Inc Leadership Team
Harrison Bains, Director, MBA
Timothy Harris, Director, Ph.D
James Connor, Director
Harry Wilcox, Director
Stelios Papadopoulos, Director, MBA
Aram Adourian, SVP, Ph.D
Stephen Hall, CFO, MBA
Jeffrey Luber, Director, MBA
Raul Diaz, VP
Paul Sohmer, CEO
Noubar Afeyan, Founder
James OConnor, Director

Stock Performance

BG Medicine Performance Indicators